Literature DB >> 21484160

Relationship between the paraoxonase (PON1) L55M and Q192R polymorphisms and obesity in a Mexican population: a pilot study.

Maria Fernanda Martínez-Salazar1, Damianys Almenares-López, Sara García-Jiménez, Miguel Angel Sánchez-Alemán, Alina Juantorena-Ugás, Camilo Ríos, Antonio Monroy-Noyola.   

Abstract

The aim of this study was to examine the relationship between the L55M and Q192R paraoxonase (PON1) polymorphisms and obesity in a population of adult Mexican workers. The study population included 127 adult individuals from the Universidad Autónoma del Estado de Morelos, ranging in age from 20 to 56 years and representing both sexes. Based on body mass index, 63 individuals were classified as obese and 64 as normal weight. The PON1-Q192R and PON1-L55M polymorphisms were determined by restriction fragment length polymorphism PCR analysis. Both arylesterase and paraoxonase activity levels were similar in both groups, whereas systolic pressure, triglyceride, total cholesterol, low-density lipoprotein cholesterol, very-low-density lipoprotein cholesterol, glucose, and insulin levels were higher in the obese group than in the normal-weight group (P < 0.05). An exception was the high-density lipoprotein cholesterol (HDL-C) levels, which were lower in the obese group (P < 0.05). Although the PON1-Q192R polymorphism was not associated with either group, the frequency of the homozygous L genotype for the PON1-L55M polymorphism was higher in the obese group than in the normal-weight group (P < 0.05). In conclusion, this study established a positive association between the PON1-L55M homozygous L genotype and obesity.

Entities:  

Year:  2011        PMID: 21484160      PMCID: PMC3197847          DOI: 10.1007/s12263-011-0215-0

Source DB:  PubMed          Journal:  Genes Nutr        ISSN: 1555-8932            Impact factor:   5.523


  38 in total

1.  Study of factors influencing the decreased HDL associated PON1 activity with aging.

Authors:  Ildiko Seres; Gyorgy Paragh; Elaine Deschene; Tamas Fulop; Abdelouahed Khalil
Journal:  Exp Gerontol       Date:  2004-01       Impact factor: 4.032

2.  Adipocytes recognize and degrade oxidized low density lipoprotein through CD36.

Authors:  Akihiko Kuniyasu; Shigeki Hayashi; Hitoshi Nakayama
Journal:  Biochem Biophys Res Commun       Date:  2002-07-12       Impact factor: 3.575

3.  Adiposity and cardiovascular risk factors in a large contemporary population of pre-pubertal children.

Authors:  Emanuela Falaschetti; Aroon D Hingorani; Alexander Jones; Marietta Charakida; Nicholas Finer; Peter Whincup; Debbie A Lawlor; George Davey Smith; Naveed Sattar; John E Deanfield
Journal:  Eur Heart J       Date:  2010-10-23       Impact factor: 29.983

4.  Leptin in obesity.

Authors:  T I Sørensen; S Echwald; J C Holm
Journal:  BMJ       Date:  1996-10-19

5.  Paraoxonase polymorphism (Gln192-Arg) is associated with coronary heart disease in Japanese noninsulin-dependent diabetes mellitus.

Authors:  M Odawara; Y Tachi; K Yamashita
Journal:  J Clin Endocrinol Metab       Date:  1997-07       Impact factor: 5.958

6.  The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux.

Authors:  Mira Rosenblat; Leonid Gaidukov; Olga Khersonsky; Jacob Vaya; Roni Oren; Dan S Tawfik; Michael Aviram
Journal:  J Biol Chem       Date:  2006-01-10       Impact factor: 5.157

7.  Paraoxonase 1 polymorphisms and survival.

Authors:  L Christiansen; L Bathum; H Frederiksen; K Christensen
Journal:  Eur J Hum Genet       Date:  2004-10       Impact factor: 4.246

8.  Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon.

Authors:  C E Furlong; R J Richter; S L Seidel; A G Motulsky
Journal:  Am J Hum Genet       Date:  1988-09       Impact factor: 11.025

9.  Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.

Authors:  H B Hubert; M Feinleib; P M McNamara; W P Castelli
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

10.  Changes on the physiological lactonase activity of serum paraoxonase 1 by a diet intervention for weight loss in healthy overweight and obese women.

Authors:  Kazuhiko Kotani; Naoki Sakane; Yoshiko Sano; Kokoro Tsuzaki; Yukiyo Matsuoka; Kahori Egawa; Makiko Yoshimura; Chika Horikawa; Yoshinori Kitagawa; Yoshinobu Kiso; Satoshi Kimura; John Schulze; Jennifer Taing; Alejandro Gugliucci
Journal:  J Clin Biochem Nutr       Date:  2009-10-28       Impact factor: 3.114

View more
  5 in total

1.  Paraoxonase enzyme activity and dyslipidemia in chronic kidney disease patients.

Authors:  Mehrdad Solati; Hamid-Reza Mahboobi
Journal:  J Nephropathol       Date:  2012-10-01

2.  Associations of PON1 and genetic ancestry with obesity in early childhood.

Authors:  Karen Huen; Kim Harley; Kenneth Beckman; Brenda Eskenazi; Nina Holland
Journal:  PLoS One       Date:  2013-05-03       Impact factor: 3.240

Review 3.  Genetics of oxidative stress in obesity.

Authors:  Azahara I Rupérez; Angel Gil; Concepción M Aguilera
Journal:  Int J Mol Sci       Date:  2014-02-20       Impact factor: 5.923

4.  Paraoxonase1 genetic polymorphisms in a mixed ancestry African population.

Authors:  M Macharia; A P Kengne; D M Blackhurst; R T Erasmus; T E Matsha
Journal:  Mediators Inflamm       Date:  2014-11-16       Impact factor: 4.711

5.  A targeted multi-omics approach reveals paraoxonase-1 as a determinant of obesity-associated fatty liver disease.

Authors:  Sara Diels; Bart Cuypers; Asta Tvarijonaviciute; Bruno Derudas; Evelien Van Dijck; An Verrijken; Luc F Van Gaal; Kris Laukens; Philippe Lefebvre; Jose J Ceron; Sven Francque; Wim Vanden Berghe; Wim Van Hul
Journal:  Clin Epigenetics       Date:  2021-08-13       Impact factor: 6.551

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.